| Subject: | FDA Updates Consumers on Guidant Corporation's Implantable Defibrillators |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 6 Jul 2005 - 10:00 am |
| The StayAlert Administrator posted a notice on 6-20-05 regarding the FDA recall of certain implantable defibrillators and cardiac resynchronization therapy defibrillators from Guidant Corporation. As of 7-01-05 the FDA has now classified these recalled devices manufactured by Guidant Corporation.
Classifications can fall into three categories, with Class I being the most serious. These numerical classifications are based on the probability that the device failure could lead to adverse health... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|
